ELETRIPTAN ETHYL INDOLE PROLINE - Names and Identifiers
ELETRIPTAN ETHYL INDOLE PROLINE - Physico-chemical Properties
Molecular Formula | C16H22N2
|
Molar Mass | 242.36 |
Storage Condition | 2-8°C |
ELETRIPTAN ETHYL INDOLE PROLINE - Introduction
5-Ethyl-3-[[(2R)-1-methyll-2-pyrrolidinyl] methyl]-1H-indole, also known as 5-Ethyltryptamine(5-Et,5-ET) is an organic compound with the chemical formula C17H24N2. It is a reagent containing indole structure and ethyl group, which has certain pharmacological activity.
About the properties of 5-Ethyl-3-[[(2R)-1-methyll-2-pyrrolidinyl] methyl]-1H-indole:
Appearance: Colorless to light yellow solid
Melting point: about 94-96 ° C
Solubility: Soluble in organic solvents (such as dichloromethane, methanol), insoluble in water.
Use of 5-Ethyl-3-[[(2R)-1-methyll-2-bromidinyl] methyl]-1H-indole:
5-Ethyl-3-[[(2R)-1-methyll-2-pyrrolidinyl] methyl]-1H-indole is mainly used as a reagent in biochemical research and is widely used to induce receptor activation in nervous system related research, the activity and corresponding mechanism were observed.
Preparation of 5-Ethyl-3-[[(2R)-1-methyll-2-pyrrolidinyl] methyl]-1H-indole:
5-Ethyl-3-[[(2R)-1-methyll-2-pyrrolidinyl] methyl]-1H-indole can be synthesized by a multi-step reaction. One common method is to react a suitable indole derivative with 1-methyl-2-bromobutene by ethylation and pyrrolidine cyclization.
Safety information for 5-Ethyl-3-[[(2R)-1-methyll-2-pyrrolidinyl] methyl]-1H-indole:
Data on the toxicity and safety of 5-Ethyl-3-[[(2R)-1-methyll-2-pyrrolidinyl] methyl]-1H-indole are currently insufficient and must be used with caution. Wear appropriate personal protective equipment such as goggles and gloves during operation. Avoid inhalation, ingestion or contact with skin as much as possible. When using, please follow the laboratory's safe operating procedures, and store and dispose in accordance with relevant regulations. In case of accidental ingestion or exposure, seek medical advice immediately and provide relevant chemical information.
Last Update:2024-04-10 22:29:15